IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
IDXG
Delisted
IDXG was delisted on the 24th of February, 2021.
14 hedge funds and large institutions have $2.71M invested in Interpace Biosciences, Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
14
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$63.9K | |
| 2 | +$2K | |
| 3 | +$732 | |
| 4 |
Morgan Stanley
New York
|
+$355 |
| 5 |
LCC
Lincoln Capital Corp
East Greenwich,
Rhode Island
|
+$304 |
Top Sellers
| 1 | -$353K | |
| 2 | -$133K | |
| 3 | -$93K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$20K |
| 5 |
WS
Wedbush Securities
Los Angeles,
California
|
-$9.76K |